• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

 TudorRose Consulting is now part of Adjutor Healthcare.   Same team.   More Expert Services.    Meet Adjutor

This is the official © Adjutor Healthcare Logo. It is subject to copyright and may not be used in any way or form without the express permission of Adjutor Healthcare Pty Ltd.

A global provider of development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.

  • What We Do
  • Why Choose Us
  • Who We Are
  • Helpers Blog
  • Join Our Team
  • Contact Us
  • What We Do
  • Why Choose Us
  • Who We Are
  • Helpers Blog
  • Join Our Team
  • Contact Us

Advertizing Therapeutic Goods in Australia

If you’re advertizing therapeutic goods in Australia in 2019, there’s new legislation that is critical to your successful campaign/s.

We’ve been keeping up to date over the break to ensure we’re ready to assist our clients with all of their commercialization needs around the globe.

January 18, 2019 //  by Adjutor Healthcare

Welcome Everyone to 2019!

The TGA has released new guidelines for Advertizing Therapeutic Goods in 2019. Image depicts Fireworks over Sydney Harbour Bridge, New Years Eve January 2019

Social Media Traps

If you’re advertizing therapeutic goods in Australia in 2019, there’s new legislation that is critical to your successful campaign/s.

We’ve been keeping up to date over the break to ensure we’re ready to assist our clients with all of their commercialization needs around the globe.

New Guidelines Released by Therapeutic Goods Administration (TGA)

The Therapeutic Goods Administration (TGA) published new guidance on advertizing of therapeutic goods, last November, which came into force on 1st Jan 2019.

When advertizing therapeutic goods to the public, advertizers must comply with the Therapeutic Goods Advertising Code (No 2) 2018. Not all therapeutic goods are allowed to be advertized to the public. Some examples include biologicals and goods made available solely on prescription from a registered healthcare provider (for example a doctor or dentist). This is not an exhaustive list.

The definition of advertizing includes websites and social media. TGA has now included these forms of advertizing specifically in their guidance.

As there are penalties for non-compliance, it’s important for international companies to understand the differences in advertizing rules in Australia and to seek expert local advice. In many cases, we can suggest alternative ways of getting your message across, without contravening the Therapeutic Goods Act and the Advertizing Code.

In November 2018, TGA began legal proceedings against Peptide Clinics Pty Ltd for a raft of alleged breaches. This is a cautionary tale, the details of which, can be a found here:

TGA takes aim at Peptides Clinics Australia for alleged advertising breaches.

Being effective and in compliance in your advertizing will mean that you are not the subject of this type of negative press and legal expenses, give you the edge over your competitors and make sure you’re maximising the returns from your advertizing spend.

For expert advice on your advertizing and compliance, please contact us.

Contact Us

Share this post:

TwitterFacebookLinkedInEmail

Category: AustraliaTag: Advertizing, Compliance, Regulatory, TGA

No time to waste?

Contact us today for an initial consultation and learn
how we can add value to your business.

CONTACT US TODAY

You May Also Be Interested In…

Despite the postponement of the EU Medical Devices Regulation implementation to May 2021 appearing to offer breathing room, it has actually shortened the transition time for many manufacturers!

EU MDR: Are ROW Device Sponsors Ready for the Ripple Effect?

Image depicts the Australian government 2020 budget cash splash on high tech and science recovery.

Australian Government Cash Splash on High Tech Recovery

TGA's new Product Information (PI) Form: If you need support to meet the 31 December 2020 deadline, we’re here to help.

The Pointy End of the PI Reformatting Transition Period

Therapeutic Product Commercialization - We may have a global market but do we really consider options outside of USA and EU enough when developing our strategy?

Therapeutic Product Commercialization

Medsafe NZ has been working on a new therapeutic products regulatory regime to replace and modernise the regulatory arrangements for medicines.

MEDSAFE NZ Moves Ahead in 2020

Adjutor Healthcare announces launch of Adjutor Healthcare New Zealand Limited consulting and sponsorship entity for medicines and medical devices.

Launch of Adjutor Healthcare (NZ) Limited

The Federal Court imposes $10 million penalty for the alleged Peptide Clinics advertising breaches. Peptide Clinics Pty Ltd was liquidated earlier this year.

Consumer Insecurity / Vanity Targeted by TGA – Massive Fines

Australian Employment Regulations - Compliance Alert Banner.

Australian Employment Regulations

The TGA has released new guidelines for Advertizing Therapeutic Goods in 2019. Image depicts Fireworks over Sydney Harbour Bridge, New Years Eve January 2019

Advertizing Therapeutic Goods in Australia

Footer

Company Profile

Adjutor Healthcare Pty Ltd is part of a worldwide network that spans 90 countries.

We provide seamless services across development and commercialization of your products internationally.

Read More

Contact Us

Adjutor Healthcare Pty Ltd

  +61 418 314 763

  rosalie.cull@adjutor.com.au

  • Email
  • LinkedIn
  • Phone

Email Newsletter

Sign up to receive the latest industry news updates!

© 2021 Adjutor Healthcare · All Rights Reserved · Web Services by Kracked Kreative
We use cookies to ensure that you have the best experience on our website.OKPrivacy policy